This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

HomeBrowseAboutFAQs
Log In
Sign Up
Ulcerative Colitis

Research Study in Patients With Severe Ulcerative Colitis

Sponsored by Facet Biotech

About this trial

Last updated 13 years ago

Study ID

291-406

Status

Completed

Type

Interventional

Phase

Phase 2/Phase 3

Placebo

No

Accepting

18-75 Years
18 to 70 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 20 years ago

What is this trial about?

The purpose of the study is to evaluate an intravenous (by injection) investigational medication to treat severe ulcerative colitis refractory to steroid therapy. The research is being conducted at up to 8 clinical research sites in the US and is open to both men and women ages 18 to 70 years old. Participants in the study will have a number of visits to a research site. All study-related care and medication is provided to qualified participants at no cost: this includes all visits, examinations and laboratory work.

What are the Participation Requirements?

1. A diagnosis of ulcerative colitis verified by colonoscopy or barium enema performed
within 36 months prior to study entry.

2. Active disease despite ongoing treatment with steroids

Locations

Location

Status

For more information, view the full study details:

NCT00032305